Search results
1 gru 2014 · Imaging Characteristics. Fluorescein angiography (FA), fundus autofluorescence (FAF), and spectral-domain optical coherence tomography (SD-OCT) can help diagnose and characterize Stargardt disease. The hallmark finding on imaging of Stargardt disease is a “dark choroid” on FA (Fig. 2).
- Create an Account
7 character minimum, case sensitive. You may use only...
- Log In
If you believe you have an Academy membership and are unable...
- Stargardt Disease (STGD)
Clinical Findings. Patients with STGD typically present in...
- Create an Account
8 sty 2024 · Objectives: Assess disease progression and visual function in Stargardt disease to tailor individualized treatment plans. Identify the genetics related to Stargardt disease and describe the various clinical features and differential diagnosis of this condition. Interpret the various imaging modalities used to diagnose and assess Stargardt disease.
Diagnostic evaluation of Stargardt disease is based on family history, visual acuity, fundus examination, visual field testing, fluorescein angiography, fundus autofluorescence (FAF), electroretinography (ERG) and optical-coherence tomography (OCT).
Stargardt macular dystrophy (Stargardt disease; STGD1; OMIM 248200) is the most prevalent inherited macular dystrophy. STGD1 is an autosomal recessive disorder caused by multiple pathogenic sequence variants in the large ABCA4 gene (OMIM 601691).
21 sie 2017 · Clinical Findings. Patients with STGD typically present in childhood or early adolescence, but some may present in later adulthood. Initial symptoms include bilateral central visual loss characterized by blurred vision, central scotomas, and/or dyschromatopsia.
Imaging Characteristics. Fluorescein angiography (FA), fundus autofluorescence (FAF), and spec tral-domain optical coherence tomography (SD-OCT) can help diagnose and characterize Stargardt disease.
Stargardt disease (STGD1; MIM 248200) is the most prevalent inherited macular dystrophy and is associated with disease-causing sequence variants in the gene ABCA4. Significant advances have been made over the last 10 years in our understanding of both the clinical and molecular features of STGD1, and also the underlying pathophysiology, which ...